Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy DNA-based-transposon-system-for-the-introduction-of-nucleic-acid-into-DNA-of-a-cell

 Substrate for detection of mammalian 5-C-DNA methyltransferase
OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine ...


 Vinyl ethers of nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the ...


 Nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the ...


 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
To accomplish those objectives, the present invention provides hydrophobic muiticomponent heparin ...


 Gas permeable bioreactor and method of use
OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS. 1-11 are the same. R...


 Method for treating diseases of the inner ear using adamantane derivatives
OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or ...


 Polyalkylene oxide-containing urethane polyols with sulphonic acid groups
What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane ...


 Herpes treatment
I claim: 1. A method for the control of herpes virus infections in man which comprises contacting ...


 Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is ...


 Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## ...


 DNA-based transposon system for the introduction of nucleic acid into DNA of a cell

Details
Inventors: Hackett, Perry B.; Ivics, Zoltan; Izsvak, Zsuzsanna;
Assignee: Regents of the University of Minnesota (Minneapolis, MN)
Primary Examiner: Crouch; Deborah
Assistant Examiner: Woitach; Joseph
Attorney, Agent or Firm: Mueting, Raasch & Gebhardt, P.A.

This invention relates to a system for introducing nucleic acid into the DNA of a cell. The system includes the use of a member of the SB family of transposases (SB) or nucleic acid encoding the transposase and a nucleic acid fragment that includes a nucleic acid sequence with flanking inverted repeats. The transposase recognizes at least a portion of an inverted repeats and incorporates the nucleic acid sequence into the DNA. Methods for use of this system are discussed.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention relates to novel tranposases and the transposon that are used to introduce nucleic acid sequences into the DNA of a cell.
A transposase is an enzyme that is capable of binding to DNA at regions of DNA termed inverted repeats.
Transposons typically contain at least one, and preferably two, inverted repeats that flank an intervening nucleic acid sequence.
The transposase binds to recognition sites in the inverted repeats and catalyzes the incorporation of the transposon into DNA.
Inverted repeats of an SB transposon can include two direct repeats and include at least one direct repeat.
Transposons are mobile, in that they can move from one position on DNA to a second position on DNA in the presence of a transposase.
There are two fundamental components of any mobile cut-and-paste type transposon system, a source of an active transposase and the DNA sequences that are recognized and mobilized by the transposase.
Mobilization of the DNA sequences permits the intervening nucleic acid between the recognized DNA sequences to also be mobilized.
DNA-transposons, including members of the Tc1/mariner superfamily, are ancient residents of vertebrate genomes (Radice et al.
, 1994; Smit and Riggs, 1996 Proc.
Natl.
Acad.
Sci.
USA 93, 1443-1448).
However, neither autonomous copies of this class of transposon nor a single case of a spontaneous mutation caused by a TcE insertion have been proven in vertebrate animals.
This is in contrast to retroposons whose phylogenetic histories of mutating genes in vertebrates is documented (Izsvak et al.
, 1997).
Failure to isolate active DNA-transposons from vertebrates has greatly hindered ambitions to develop these elements as vectors for germline transformation and insertional mutagenesis.
However, the apparent capability of salmonid TcEs for horizontal transmission between two teleost orders (Ivics et al.
, 1996) suggested that this particular subfamily of fish transposons might be transferred through even larger evolutionary distances



Related patents
  Methods for diagnosing sepsis
The present invention provides a pharmaceutical composition for treating conditions (diseases) mediated by the inflammatory cytokine cascade, comprising an effective ...
  Low aromatics composition
The inventions claimed is: 1. A solvent composition comprising (a) a hydrocarbon component in an amount within the range of 91 99 vol. % of said composition; and (b) an ...
  Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
The present invention describes a covalently-linked complex (CLC) for targeting a defined population of cells, comprising a targeting protein; a cytotoxic agent; and an ...
  Compositions and methods for drug delivery using pH sensitive molecules
We claim: 1. A process for transfecting a nucleic acid into a cell in vivo, comprising: a) attaching a membrane activity inhibitor to a membrane active peptide via a ...
  Chiral peptide nucleic acid monomers and oligomers
What is claimed is: 1. A peptide nucleic acid monomer having the formula: ##STR5## wherein: B is a naturally or non-naturally ocurring nucleobase; n is 0, 1, 2, or 3; ...
  Enzymatic DNA molecules
The present invention thus contemplates a synthetic or engineered (i.e., non-naturally-occurring) catalytic DNA molecule (or enzymatic DNA molecule) capable of cleaving ...
  Multigene vectors
The present invention provides a method for preparing HSV vectors. The method comprises co-transfecting a source vector and a mutating cassette together into a ...
  Composition and method for inhibiting platelet aggregation
OF THE INVENTION This invention is provides a method of preventing or treating diseases or conditions associated with platelet aggregation. The method also provides a ...
  Nucleic acid probes
OF THE INVENTION "Derivatizable" nucleotides are nucleotides modified so as to include at the 4-position of a pyrimidine a functional group which can react with a ...
  Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein
The drawings are first described. FIG. 1 is a diagram of the HSV-1 genome and oriS. FIG. 1A indicates the locations of the three origins of DNA replication and the ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved